These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 9529579)

  • 21. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nucleolar organizer regions of benign pathology of the parathyroids].
    Colecchia M; Zucchi A; Prian E; Leopardi O
    Pathologica; 1993; 85(1100):667-77. PubMed ID: 8170716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
    Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
    Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative evaluation of AgNORs in bone tumours.
    Arora B; Jindal K; Kumar S; Rekhi B; Arora H; Arora DR
    Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary gland tumors studied by means of the AgNOR technique.
    Epivatianos A; Trigonidis G
    Ann Dent; 1994; 53(2):21-5. PubMed ID: 7847771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argyrophilic nucleolar organizer regions in Wilms' tumors and related lesions: a histologic and chromosomal correlation.
    Mourad WA; Lavallee-Grey M; Pappenhausen P; Essig YP; Rowlands DT
    Mod Pathol; 1991 Mar; 4(2):247-52. PubMed ID: 1646458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor?
    Deuble K; McCartney A
    Eye (Lond); 1990; 4 ( Pt 5)():743-50. PubMed ID: 1704315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argyrophilic nucleolar organizer regions (AgNORs) in breast lesions--a study on fine needle aspirates.
    Karmakar T; Radhika S; Gupta SK
    Cytopathology; 1995 Feb; 6(1):5-13. PubMed ID: 7734703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroid pathology: evaluation of the average value of NORs and its potential diagnostic and prognostic application].
    Iuele R; Gallippi G; Giacchetto C
    Pathologica; 1994 Oct; 86(5):525-7. PubMed ID: 7739878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
    Zaczek M
    Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleolar organizer regions in jaw tumours of cartilaginous origin.
    Afolabi OC; Odukoya O; Arole G; Banjo AF
    West Afr J Med; 2001; 20(1):17-21. PubMed ID: 11505882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleolar organizer regions (NORs) in dysplastic and neoplastic epithelial lesions of the conjunctiva.
    Muscarà M; Giuffré G; Trombetta CJ; Bisantis F; Tuccari G
    Pathologica; 1991; 83(1085):281-8. PubMed ID: 1923626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The quantitative study of nucleolar organizers (AgNOR) in the diagnosis of laryngeal dysplasias and in the assessment of the prognosis in invasive carcinoma].
    Malusardi G; Oldini C; Leopardi O
    Acta Otorhinolaryngol Ital; 1992; 12(1):3-12. PubMed ID: 1632266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytology of argyrophilic carcinoma of the breast.
    Ravinsky E; Cavers DJ
    Acta Cytol; 1985; 29(1):1-6. PubMed ID: 3855579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of AgNORs in pulmonary lesions: a cyto-histopathological correlation.
    Gulati A; Sharma J; Sharma BB; Kaushik R; Kashyap S
    Indian J Pathol Microbiol; 2002 Jul; 45(3):289-92. PubMed ID: 12785168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine needle aspiration cytology combined with argyrophilic nucleolar organizer regions (AgNORs) in diagnosis of thyroid neoplasms.
    Szot W; Szybiński Z; Zaczek M; Kedra D; Dabroś E; Piotrowska K; Chłap Z
    Endokrynol Pol; 1993; 44(4):413-26. PubMed ID: 7519978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar organizer regions in squamous cell carcinoma of the head and neck.
    Hirsch SM; DuCanto J; Caldarelli DD; Hutchinson JC; Coon JS
    Laryngoscope; 1992 Jan; 102(1):39-44. PubMed ID: 1370566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.